Drug Trial Radar · NCT03197766
A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia
Last checked: Nov 19, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
Dec 12, 2016
Primary completion
Oct 30, 2019
Study completion Oct 30, 2019
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jun 23, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 5 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The intent and design of this Phase 3 study is to assess BMN 111 as a therapeutic option for the treatment of children with Achondroplasia.
Conditions
- Achondroplasia
Interventions
BMN 111Drug
Subcutaneous injection of 15 μg/kg of BMN 111 daily
PlaceboDrug
Subcutaneous injection of 15 μg/kg of placebo daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Annualized Growth Velocity (AGV) at Week 52Time frame: At Baseline and Week 52
Locations
24 sites in 7 countries. Site status is shown where the registry gives one.
Children's Hospital & Research Center Oakland
Oakland, California
Harbor - UCLA Medical Center
Torrance, California
Alfred I. duPont Hospital for Children
Wilmington, Delaware
Emory University
Decatur, Georgia
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Johns Hopkins University
Baltimore, Maryland
University of Missouri
Columbia, Missouri
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Baylor College of Medicine
Houston, Texas
Seattle Children's Hospital
Seattle, Washington
Medical College of Wisconsin, Children's Hospital
Milwaukee, Wisconsin
The Children's Hospital at Westmead
Westmead, New South Wales, Australia
Murdoch Children's Research Institute
Parkville, Victoria, Australia
Otto-von-Guericke Universitaet, Universitaetskinderklinik
Magdeburg, Germany
Universitätsklinikum Münster
Münster, Germany
Osaka University Hospital
Osaka, Japan
Saitama Children's Medical Center
Saitama, Japan
Tokushima University Hospital
Tokushima, Japan
Institut Catala de Traumatologica I Medicina de l'Esport
Barcelona, Spain
Hospital Sant Joan de Deu
Barcelona, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Spain
Acibadem University School of Medicine
Istanbul, Turkey (Türkiye)
Guy's and St. Thomas NHS Foundation Trust Evelina Children's Hospital
London, United Kingdom
Sheffield Children's NHS Foundation Trust
Sheffield, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.